The Annual Report

Lufax Announces Annual General Meeting on May 30, 2024 and Filing of Its Annual Report on Form 20-F

Retrieved on: 
Dienstag, April 23, 2024
The Annual Report, Annual, Stock exchange, Small business, HKEX, Republic, Annual report, Proxy, Room, ADS, Exercise, Bank statement, AGM, Cryptocurrency

The AGM notice, the AGM circular, and the form of proxy for the AGM are available on the Company's website at https://ir.lufaxholding.com .

Key Points: 
  • The AGM notice, the AGM circular, and the form of proxy for the AGM are available on the Company's website at https://ir.lufaxholding.com .
  • The Company also announced today that it filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission on April 23, 2024.
  • The Annual Report can be accessed on the Company's investor relations website at https://ir.lufaxholding.com .
  • The Company will also provide a hard copy of its Annual Report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request.

Dingdong Files Its Annual Report on Form 20-F

Retrieved on: 
Freitag, April 19, 2024
DDL, The Annual Report, ADS, Annual, Annual report, Bank statement, Cayman, Security (finance)

SHANGHAI, April 19, 2024 /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE: DDL), a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced that it filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission on April 19, 2024.

Key Points: 
  • SHANGHAI, April 19, 2024 /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE: DDL), a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced that it filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission on April 19, 2024.
  • The Annual Report can be accessed on the Company's investor relations website at https://ir.100.me .
  • The Company will also provide a hard copy of its Annual Report containing the audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request.

Cairn Homes Plc: Replacement - Annual Report and Notice of AGM

Retrieved on: 
Mittwoch, April 10, 2024
Euronext Dublin, Annual, Financial statement, Letter, Annual report, Proxy, The Annual Report, Merrion Hotel

Dublin / London, 26 March 2024: Cairn Homes plc (“Cairn”, “the Company” or “the Group”), announces that its Annual Report for the year ended 31 December 2023, together with the Letter from the Chairman and 2024 Notice of Annual General Meeting and Form of Proxy have been issued to shareholders.

Key Points: 
  • Dublin / London, 26 March 2024: Cairn Homes plc (“Cairn”, “the Company” or “the Group”), announces that its Annual Report for the year ended 31 December 2023, together with the Letter from the Chairman and 2024 Notice of Annual General Meeting and Form of Proxy have been issued to shareholders.
  • The Annual General Meeting will be held on 10 May 2024 at 12:00 noon in The Merrion Hotel, Merrion Street Upper, Dublin 2, Ireland.
  • Copies of the above documents (including the Annual Report and Financial Statements for the year ended 31 December 2023 in ESEF compliant format) are also available on the Company's website, www.cairnhomes.com .
  • The Annual Report will also be submitted to the UK National Storage Mechanism and Euronext Dublin, and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and at the following address:

Cairn Homes Plc: Annual Report and Notice of Annual General Meeting

Retrieved on: 
Mittwoch, April 10, 2024
Euronext Dublin, Annual, Financial statement, Letter, Annual report, Proxy, The Annual Report, Merrion Hotel

Dublin / London, 26 March 2024: Cairn Homes plc (“Cairn”, “the Company” or “the Group”), announces that its Annual Report for the year ended 31 December 2023, together with the Letter from the Chairman and 2024 Notice of Annual General Meeting and Form of Proxy have been issued to shareholders.

Key Points: 
  • Dublin / London, 26 March 2024: Cairn Homes plc (“Cairn”, “the Company” or “the Group”), announces that its Annual Report for the year ended 31 December 2023, together with the Letter from the Chairman and 2024 Notice of Annual General Meeting and Form of Proxy have been issued to shareholders.
  • The Annual General Meeting will be held on 10 May 2023 at 12:00 noon in The Merrion Hotel, Merrion Street Upper, Dublin 2, Ireland.
  • Copies of the above documents (including the Annual Report and Financial Statements for the year ended 31 December 2023 in ESEF compliant format) are also available on the Company's website, www.cairnhomes.com .
  • The Annual Report will also be submitted to the UK National Storage Mechanism and Euronext Dublin, and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and at the following address:

Funding Circle Plc: Publication of 2023 Annual Report and Notice of 2024 AGM

Retrieved on: 
Mittwoch, April 10, 2024
Annual report, National Storage, AGM, The Annual Report

The Company has also today made the following documents available to shareholders:

Key Points: 

Aperam announces the publication of its Annual Report 2023

Retrieved on: 
Mittwoch, April 10, 2024
Annual, Luxembourg Stock Exchange, Report, Documentation, Annual report, The Annual Report

Luxembourg March 26, 2024 (07:00 CET) - Aperam announces the publication of its 2023 Annual Report.

Key Points: 
  • Luxembourg March 26, 2024 (07:00 CET) - Aperam announces the publication of its 2023 Annual Report.
  • The report has been filed with the electronic database of the Luxembourg Stock Exchange (www.bourse.lu) and is available on www.aperam.com under "Investors" > "Reports & Presentations” > “ Annual Reports ".
  • The Annual Report 2023 is part of the documentation for the upcoming annual general meeting of shareholders scheduled on April 30, 2024.

EQS-News: NOTICE TO CONVENE MULTITUDE SE’S ANNUAL GENERAL MEETING OF SHAREHOLDERS

Retrieved on: 
Mittwoch, April 10, 2024
Appendix, Letter, Exercise, EEST, The Annual Report, Audit committee, Annual, Audit, Annual general meeting, Remuneration, Report, Register, Person, PwC, Proxy, Book, Annual report, Chapter Five, Auditor, EUR, Chapter Ten, Frankfurt Stock Exchange, Notice, Address, KHT, Mass meeting, Treasury, ID, Malta Business Registry, Security (finance)

The Board of Directors proposes to the Annual General Meeting that, for the financial year 2023, a dividend of EUR 0.19 per share be distributed.

Key Points: 
  • The Board of Directors proposes to the Annual General Meeting that, for the financial year 2023, a dividend of EUR 0.19 per share be distributed.
  • Shareholders, who are registered in the shareholders’ register of the Company, and who wish to participate in the General Meeting, must register for the meeting by giving prior notice of participation as instructed below.
  • Shareholders may participate in the General Meeting of Shareholders and exercise their rights at the meeting by way of proxy representation.
  • On the date of this notice to the Annual General Meeting of Shareholders, dated 28 March 2024, the total number of shares in Multitude SE is 21,723,960 and each of these shares carries one vote.

EQS-News: Heidelberg Pharma announces progress into Cohort 6 with its proprietary ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study

Retrieved on: 
Mittwoch, April 10, 2024
Multiple myeloma, Bone marrow, Cohort, Infection, Incidence, BCMA, Patient, Plasma cell, Mortality, B cell, Spacecraft, AACR, Annual report, Antibody, The Annual Report, Safety, Pharmacokinetics, HPHA, FDA, ATAC, Food, Pharmaceutical industry

Multiple myeloma is a type of blood cancer that develops from plasma cells in the bone marrow and can affect more than one part of the body.

Key Points: 
  • Multiple myeloma is a type of blood cancer that develops from plasma cells in the bone marrow and can affect more than one part of the body.
  • Plasma cells are a type of blood cell that makes antibodies to fight infection, created by bone marrow.
  • Heidelberg Pharma’s Phase I/IIa clinical study is an ongoing, non-randomised, open label study which is actively enrolling patients with relapsed or refractory multiple myeloma or other plasma cell disorders expressing BCMA.
  • Prof. Dr. Andreas Pahl, Chief Executive Officer at Heidelberg Pharma, said: “Our proprietary ATAC candidate HDP-101 is showing exciting potential for treating multiple myeloma.

EQS-News: centrotherm international AG: Preliminary Group figures for 2023 confirm positive business development; Management Board examines strategic financing options to accelerate further growth

Retrieved on: 
Mittwoch, April 10, 2024
EUR, Annual, Growth, Environment, Intelligence, Research, Overalls, Blaubeuren, Annual general meeting, Investment, Annual report, The Annual Report, Silicon, Management

centrotherm international AG: Preliminary Group figures for 2023 confirm positive business development; Management Board examines strategic financing options to accelerate further growth

Key Points: 
  • centrotherm international AG: Preliminary Group figures for 2023 confirm positive business development; Management Board examines strategic financing options to accelerate further growth
    The issuer is solely responsible for the content of this announcement.
  • centrotherm international AG: Preliminary Group figures for 2023 confirm positive business development; Management Board examines strategic financing options to accelerate further growth
    Blaubeuren, March 14, 2024 - centrotherm international AG today published preliminary, unaudited figures for the 2023 financial year in an ad hoc announcement.
  • In contrast, EBITDA is expected to reach the forecast of a positive EBITDA in the low double-digit million range at EUR 19 million.
  • Based on these positive preliminary business figures for 2023, the Executive Board believes that its strategy has been confirmed overall and has therefore decided today to examine strategic financing options.

Bango PLC ("Bango" or the "Company") 2023 Full Year Results and 2024 Outlook

Retrieved on: 
Montag, April 8, 2024
Annual, DVM, Growth, ARR, NHN Entertainment Corporation, Digital, Wind, Investment, Annual report, The Annual Report, Depreciation, Music, BST, NHN, Video game

And, to transfer the technology developed in the joint venture to Bango and NHN so both can use it without restriction in their respective core businesses.

Key Points: